Christopher Cano

Christopher Cano

Fondateur chez
C2 Strategic LLC
55 ans
Health Technology
Consumer Services
Commercial Services

Profil

Christopher Cano has founded C2 Strategic LLC in 2011, where he is currently the Managing Partner.
He has held former positions at Noven Pharmaceuticals, Inc., Barrier Therapeutics, Inc., Agile Therapeutics, Inc., Almirall LLC, Nucryst Pharmaceuticals Corp.
(New Jersey), Liberty Medical LLC, TFF Pharmaceuticals, Inc., and Duchesnay USA, Inc. At TFF Pharmaceuticals, Inc., he was the Vice President-Business Development from 2018 to 2020.
Mr. Cano has a graduate degree from Rider University and an undergraduate degree from Villanova University.

Postes actifs de Christopher Cano

SociétésPosteDébut
C2 Strategic LLC
Fondateur 01/01/2011

Anciens postes connus de Christopher Cano

SociétésPosteFin
TFF PHARMACEUTICALS, INC. Directeur des opérations 18/12/2023
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
AGILE THERAPEUTICS, INC. Corporate Officer/Principal -
Voir l'expérience en détail de Christopher Cano

Formation de Christopher Cano

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés liées

Entreprise privées11

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Retail Trade

Health Technology

Health Technology

C2 Strategic LLC

  1. Bourse
  2. Insiders
  3. Christopher Cano
🔇